340B Pricing Retraction
Effective immediately, the Department of Aging is withdrawing the June 21, 2010 Bulletin mandating that providers submitting claims using pharmaceuticals purchased through the 340B Drug Discount Program bill the Program a Usual and Customary price that reflected the 340B discounted price.
However, to insure accuracy for the Department's manufacturer's rebate program, it is important that pharmaceuticals submitted to the Program for reimbursement, obtained by the pharmacy using the 340B Drug Discount Program, be identified as 340B medications. This identification should be made by submitting all claims using 340B purchased medications with a value of "09" or "08" in the Basis of Cost Determination (Field 423-DN). The value of "09" (NCDP definition of Other) or "08" should be used to identify these 340B claims. NOTE: NCPDP Version D.0 and above designates the value 08 as "340B /Disproportionate Share Pricing/Public Health Service."
NOTE: This field, Basis of Cost Determination (Field 423-DN), will only be used for manufacturer rebate processing by the Department. Questions may be directed to Provider Services at 1-800-835-4080.